JNJ-42314415

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameJNJ-42314415
Drug Alias NameJNJ-42314415
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 10A inhibitors
TargetsPhosphodiesterase 10A
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson
Inactive CompaniesN/A
Active IndicationsPsychotic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A